Author

Waqqas Afif 1

1 McGill University Health Centre,Montreal,Canada

BENEFITS OF IMPLEMENTING A RAPID ACCESS CLINIC IN A HIGH VOLUME INFLAMMATORY BOWEL DISEASE CENTER: ACCESS, RESOURCE UTILIZATION AND OUTCOMES

Sofia Nene, Zsuzsanna Kürti, Isabelle Morin, Talat Bessissow, Waqqas Afif, Gary Wild, Ernest Seidman, Alain Bitton, Peter L Lakatos

Benefits of implementing a rapid access clinic in a high volume inflammatory bowel disease center: access, resource utilization and outcomes

Sofia Nene, Lorant Gonczi, Christine Verdon, Jason Reinglas, Rita Kohen, Talat Bessissow, Waqqas Afif, Gary Wild, Ernest Seidman, Alain Bitton, Peter L Lakatos

CONCORDANCE BETWEEN TUBERCULIN SKIN TEST AND INTERFERON GAMMA RELEASE ASSAY FOR LATENT TUBERCULOSIS SCREENING IN INFLAMMATORY BOWEL DISEASE (META-ANALYSIS).

Saad Alrajhi, Pascale Germain, Myriam Martel, Waqqas Afif

CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

Ramesh P. Arasaradnam, Ellen J. Scherl, David Rowbotham, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Waqqas Afif, Tadakazu Hisamatsu, Rupert W Leong, Bruce E. Sands, Maria T. Abreu, Colleen W. Marano

EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN´S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

Ahmad Albshesh, Joshua Taylor, Edoardo Vincenzo Savarino, Marie Truyens, Alessandro Armuzzi, Davide Giuseppe Ribaldone, Ariella Shitrit, Morine Fibelman, Pauliina Molander, Claire Liefferinckx, Stephane Nancy, Mohamed Korani, Klaudia Farkas, Manuel Barreiro de Acosta, Viktor Domislovic, Gerard Surís, Carl Eriksson, Catarin

EFFECTIVENESS, SAFETY, AND DRUG SUSTAINABILITY OF BIOLOGICS IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER RETROSPECTIVE STUDY

Gustavo Hahn, Jean-Frédéric LeBlanc, Petra Anna Golovics, Panu Wetwittayakhlang, Abdulrahman Qatomah, Anna Wang, Levon Boodaghians, Jeremy Kiow, Maryam Al Ali, Gary Wild, Waqqas Afif, Alain Bitton, Peter L Lakatos, Talat Bessissow

EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

Waqqas Afif, Maria T. Abreu, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Tadakazu Hisamatsu, Ellen J. Scherl, Rupert W Leong, David Rowbotham, Ramesh P. Arasaradnam, Laurent Peyrin-Biroulet, Bruce E. Sands, Colleen W. Marano

EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

Waqqas Afif

EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS IN PATIENTS THROUGH 3 YEARS: UNIFI LONG-TERM EXTENSION

David Rowbotham, Maria T. Abreu, Silvio Danese, William J. Sandborn, Ye Miao, Hongyan Zhang, Remo Panaccione, Tadakazu Hisamatsu, Ellen Scherl, Rupert W Leong, Ramesh P. Arasaradnam, Waqqas Afif, Laurent Peyrin-Biroulet, Bruce E. Sands, Colleen W. Marano

MUCOSAL HEALING AND CLINICAL EFFICACY OF ADALIMUMAB IN SMALL INTESTINAL CROHN’S DISEASE (SIMCHA STUDY): FINAL RESULTS FROM A PROSPECTIVE, OPEN-LABEL, SINGLE-ARM STUDY

Panu Wetwittayakhlang, Christine Verdon, Gustavo Hahn, Petra Golovics, Talat Bessissow, Waqqas Afif, Gary Wild, Alain Bitton, Peter L Lakatos

Item 1 - 10 / 20
1
2